Testing effectiveness (Phase 2)Looking for participantsNCT06017869
What this trial is testing
Evaluate the Safety and Therapeutic Effects of a Single Intravenous Infusion (IV) of Autologous CD34+ Cells Enriched With Allogenic Placenta-derived Mitochondria in Patients With a Diagnosis of Pearson Syndrome (PS)
Who this might be right for
Mitochondrial DiseasesPearson Syndrome
Minovia Therapeutics Ltd. 6